These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 25784290

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma.
    Fujiwara T, Uotani K, Yoshida A, Morita T, Nezu Y, Kobayashi E, Yoshida A, Uehara T, Omori T, Sugiu K, Komatsubara T, Takeda K, Kunisada T, Kawamura M, Kawai A, Ochiya T, Ozaki T.
    Oncotarget; 2017 May 16; 8(20):33375-33392. PubMed ID: 28380419
    [Abstract] [Full Text] [Related]

  • 3. A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma.
    Huang C, Wang Q, Ma S, Sun Y, Vadamootoo AS, Jin C.
    Int J Clin Oncol; 2019 Aug 16; 24(8):976-982. PubMed ID: 31111286
    [Abstract] [Full Text] [Related]

  • 4. Serum miR-542-3p as a prognostic biomarker in osteosarcoma.
    Li Q, Song S, Ni G, Li Y, Wang X.
    Cancer Biomark; 2018 Feb 14; 21(3):521-526. PubMed ID: 29103020
    [Abstract] [Full Text] [Related]

  • 5. Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma.
    Lian F, Cui Y, Zhou C, Gao K, Wu L.
    PLoS One; 2015 Feb 14; 10(3):e0121499. PubMed ID: 25775010
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Circulating miR-215-5p and miR-642a-5p as potential biomarker for diagnosis of osteosarcoma in Mexican population.
    Monterde-Cruz L, Ramírez-Salazar EG, Rico-Martínez G, Linares-González LM, Guzmán-González R, Delgado-Cedillo E, Estrada-Villaseñor E, Valdés-Flores M, Velázquez-Cruz R, Hidalgo-Bravo A.
    Hum Cell; 2018 Oct 14; 31(4):292-299. PubMed ID: 29907935
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
    Yang Z, Zhang Y, Zhang X, Zhang M, Liu H, Zhang S, Qi B, Sun X.
    Biomed Pharmacother; 2015 Oct 14; 75():153-8. PubMed ID: 26422796
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Single nucleotide polymorphism of hsa-miR-124a affects risk and prognosis of osteosarcoma.
    Shi ZW, Wang JL, Zhao N, Guan Y, He W.
    Cancer Biomark; 2016 Jun 24; 17(2):249-57. PubMed ID: 27540978
    [Abstract] [Full Text] [Related]

  • 18. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
    Wang Z, Cai H, Lin L, Tang M, Cai H.
    Pediatr Blood Cancer; 2014 Feb 24; 61(2):206-10. PubMed ID: 24038809
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Identification of miR-199a-5p in serum as noninvasive biomarkers for detecting and monitoring osteosarcoma.
    Zhou G, Lu M, Chen J, Li C, Zhang J, Chen J, Shi X, Wu S.
    Tumour Biol; 2015 Nov 24; 36(11):8845-52. PubMed ID: 26069101
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.